Bangalore-based biosciences company Bigtec has bagged the prestigious "Red Herring 100 Global" Award. The company was chosen as one of the top 100 tech start-ups in the world. The prestigious recognition comes to Bigtec for its technology innovations in the healthcare area.
The 100 winners were selected from technical fields covering internet, new energies, semiconductor, biosciences, and services. Bigtec is the only company from India selected from the biosciences sector.
For the first time, Red Herring pooled more than 1800 eligible promising companies from its 2005, 2006 and 2007 winners and finalists of its Red Herring 100 awards to select the top 100 privately held companies in the world. Evaluations were made on both quantitative and qualitative criteria such as financial performance, innovation, management, global strategy, and ecosystem integration.
"We are elated that our work has received global recognition. This will spur us on to productize the innovative ideas in our pipeline with greater zeal" said Gopalkrishna Kini, managing director, Bigtec.
The 7-year old company has developed a DNA based diagnostics platform which doctors can use at clinics to accurately and rapidly identify pathogens. The affordable platform could be customized to detect a wide range of diseases. The affordable Micro-Electro-Mechanical Systems (MEMS) based diagnostic products will provide the much needed relief in the rural and urban healthcare in India besides developed countries.
The company's software product, ClinOne helps to automate and accelerate the management of phase I and BA/BE clinical trials. The tool absorbs definitions of every trial protocol and provides a paperless-transaction, regulatory compliant system through the clinical and analytical parts of the phase I or BA/BE study.
At the award ceremony held at Seattle, WA, Alex Vieux, CEO, Red Herring said that Bigtec is transforming the diagnostics and phase I trial scenario.